{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:51:28Z","timestamp":1795089088113,"version":"4.10.2"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5,1]]},"DOI":"10.1309\/ajcpuaac16liwzmm","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T17:01:52Z","timestamp":1429030912000},"page":"635-644","source":"Crossref","is-referenced-by-count":83,"title":["CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms"],"prefix":"10.1093","volume":"143","author":[{"given":"Seon Young","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongok","family":"Im","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Nae","family":"Park","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiseok","family":"Kwon","sequence":"additional","affiliation":[{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Ah","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Soon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea"},{"name":"Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,5,1]]},"reference":[{"key":"key\n\t\t\t\t20180602034916_b1-1430635","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"key\n\t\t\t\t20180602034916_b2-1430635","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa065202","article-title":"JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis","volume":"356","author":"Scott","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602034916_b3-1430635","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180602034916_b4-1430635","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1182\/blood-2005-03-1320","article-title":"Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders","volume":"106","author":"Jones","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034916_b5-1430635","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1312542","article-title":"Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2","volume":"369","author":"Nangalia","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602034916_b6-1430635","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa1311347","article-title":"Somatic mutations of calreticulin in myeloproliferative neoplasms","volume":"369","author":"Klampfl","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180602034916_b7-1430635","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1002\/ajh.23743","article-title":"Type 1 vs type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients","volume":"89","author":"Tefferi","year":"2014","journal-title":"Am J Hematol"},{"key":"key\n\t\t\t\t20180602034916_b8-1430635","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/leu.2014.83","article-title":"Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034916_b9-1430635","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2014-03-530865","article-title":"From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms","volume":"123","author":"Cazzola","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034916_b10-1430635","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2013-11-539098","article-title":"JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes","volume":"123","author":"Rumi","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034916_b11-1430635","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood-2013-11-538983","article-title":"Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia","volume":"123","author":"Rotunno","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034916_b12-1430635","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","article-title":"DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status","volume":"29","author":"Gangat","year":"2011","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602034916_b13-1430635","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180602034916_b14-1430635","volume-title":"ISCN 2013: An International System for Human Cytogenetic Nomenclature","author":"International Standing Committee on Human Cytogenetic Nomenclature","year":"2013"},{"key":"key\n\t\t\t\t20180602034916_b15-1430635","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/leu.2014.138","article-title":"Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment","volume":"28","author":"Fu","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034916_b16-1430635","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/leu.2014.3","article-title":"CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034916_b17-1430635","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1080\/10428190600687927","article-title":"Inferior prognostic outcome in acute promyelocytic leukemia with alterations of FLT3 gene","volume":"47","author":"Yoo","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180602034916_b18-1430635","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3346\/jkms.2008.23.5.833","article-title":"Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia","volume":"23","author":"Bang","year":"2008","journal-title":"J Korean Med Sci"},{"key":"key\n\t\t\t\t20180602034916_b19-1430635","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1038\/leu.2014.66","article-title":"Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Panagiota","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034916_b20-1430635","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/leu.2014.148","article-title":"Calreticulin mutations and long-term survival in essential thrombocythemia","volume":"28","author":"Tefferi","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t20180602034916_b21-1430635","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1182\/blood-2014-01-547596","article-title":"Two faces of ET: CALR and JAK2","volume":"123","author":"Chao","year":"2014","journal-title":"Blood"},{"key":"key\n\t\t\t\t20180602034916_b22-1430635","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceca.2013.05.006","article-title":"Calreticulin for better or for worse, in sickness and in health, until death do us part","volume":"54","author":"Eggleton","year":"2013","journal-title":"Cell Calcium"},{"key":"key\n\t\t\t\t20180602034916_b23-1430635","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1096\/fj.09-145482","article-title":"Calreticulin: non-endoplasmic reticulum functions in physiology and disease","volume":"24","author":"Gold","year":"2010","journal-title":"FASEB J"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/143\/5\/635\/24999092\/ajcpath143-0635.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T08:52:30Z","timestamp":1566550350000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/143\/5\/635\/1760857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,1]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,1]]},"published-print":{"date-parts":[[2015,5,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpuaac16liwzmm","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2015,5,1]]},"published":{"date-parts":[[2015,5,1]]}}}